US Stock MarketDetailed Quotes
PDLI PDL BioPharma
- 0.000
- 0.0000.00%
Close Jul 15 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)114.23MShares2.84052wk High0.00P/B0Float Cap2.39052wk Low--Dividend TTM79.15MShs Float21.801Historical High--Div YieldTTM0.00%Amplitude0.863Historical Low--Avg Price1Lot Size
PDL BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | (FY)Dec 31, 2018 | (Q4)Dec 31, 2018 | (Q3)Sep 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -30.13%5.21M | -10.47%6M | -4.13%30.71M | 75.33%-29.85M | -34.95%44.17M | -83.99%7.46M | -82.62%6.7M | -89.41%32.03M | -279.84%-120.96M | 19.75%67.9M |
| Operating revenue | -30.13%5.21M | -10.47%6M | -4.13%30.71M | 75.33%-29.85M | -34.95%44.17M | -83.99%7.46M | -82.62%6.7M | -89.41%32.03M | -279.84%-120.96M | 19.75%67.9M |
| Cost of revenue | -46.46%2.64M | -24.74%2.86M | 27.45%17.28M | 2.33%-22.92M | 26.05%15.03M | -66.06%4.93M | -64.04%3.8M | -55.61%13.56M | -231.03%-23.46M | 114.30%11.93M |
| Gross profit | 1.70%2.57M | 8.25%3.14M | -27.30%13.43M | 92.89%-6.93M | -47.95%29.13M | -92.11%2.53M | -89.64%2.9M | -93.20%18.47M | -297.55%-97.5M | 9.46%55.97M |
| Operating expense | 8.23%12.76M | 46.44%16.28M | 21.97%53.78M | 113.11%3.42M | 4.02%19.69M | -56.32%11.79M | -54.18%11.12M | -53.78%44.09M | -212.13%-26.08M | -20.68%18.93M |
| Selling and administrative expenses | 3.79%10.96M | 42.80%14.12M | 12.73%45.14M | 140.71%5.59M | -17.24%13.8M | -46.99%10.56M | -42.43%9.89M | -36.77%40.04M | -184.33%-13.73M | -1.78%16.68M |
| -Selling and marketing expense | -33.53%1.24M | -20.58%1.25M | 7.33%6.81M | 103.63%291K | -50.65%1.71M | -65.44%1.86M | -71.45%1.57M | -64.14%6.34M | -223.69%-8.03M | -30.54%3.47M |
| -General and administrative expense | 11.78%9.72M | 54.81%12.87M | 13.75%38.33M | 192.91%5.3M | -8.47%12.09M | -40.15%8.7M | -28.71%8.31M | -26.16%33.7M | -158.24%-5.7M | 10.19%13.21M |
| Research and development costs | 65.35%1.47M | 103.96%1.86M | 166.40%7.35M | 110.66%1.29M | 541.37%4.31M | 29.53%886K | 14.75%910K | -62.62%2.76M | -16.32%610K | 11.07%672K |
| Depreciation amortization depletion | -2.62%335K | -5.03%302K | -0.31%1.29M | 73.34%-3.46M | -0.13%1.58M | -94.61%344K | -94.95%318K | -94.76%1.29M | -307.33%-12.96M | -74.87%1.58M |
| -Depreciation and amortization | -2.62%335K | -5.03%302K | -0.31%1.29M | 73.34%-3.46M | -0.13%1.58M | -94.61%344K | -94.95%318K | -94.76%1.29M | -307.33%-12.96M | -74.87%1.58M |
| Operating profit | -10.01%-10.18M | -59.90%-13.14M | -57.49%-40.35M | 85.51%-10.35M | -74.51%9.44M | -282.62%-9.26M | -322.62%-8.22M | -114.53%-25.62M | -373.68%-71.43M | 35.84%37.04M |
| Net non-operating interest income expense | 81.78%-243K | 103.61%39K | 11.79%-5.37M | 17.23%-1.41M | -20.70%-1.55M | 7.04%-1.33M | 35.31%-1.08M | -644.74%-6.09M | 50.41%-1.7M | -207.71%-1.29M |
| Non-operating interest income | -95.82%69K | -72.63%513K | -0.58%6.03M | -12.40%1.05M | -7.65%1.46M | 19.91%1.65M | -2.09%1.87M | -68.74%6.07M | -30.13%1.19M | -74.86%1.58M |
| Non-operating interest expense | -89.74%120K | -83.96%474K | -7.77%4.96M | -2.73%-3.99M | 5.06%3.01M | -58.38%1.17M | -17.57%2.96M | -73.38%5.38M | -175.50%-3.88M | -43.76%2.87M |
| Total other finance cost | -89.42%192K | ---- | -4.94%6.44M | ---- | ---- | --1.81M | ---- | --6.78M | ---- | ---- |
| Other net income (expense) | -3.58M | -33.14M | -101.43%-15.72M | -127.36%-33.41M | -9,105.96%-27.8M | -187.11%-7.81M | 1,368.51%122.09M | 89.85%-302K | ||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --764K | ---- | ---- |
| Earnings from equity interest | ---- | ---13.8M | ---- | ---- | ---27.38M | ---- | --0 | ---- | ---- | --0 |
| Special income (charges) | ---3.58M | ---19.34M | -83.48%-15.72M | -112.61%-15.3M | -40.40%-424K | --0 | --0 | -195.64%-8.57M | 1,359.32%121.33M | 89.85%-302K |
| -Less：Restructuring and merger&acquisition | --3.58M | --18.73M | --0 | --0 | --0 | --0 | --0 | 5.73%369K | 860.07%22.8M | -56.86%302K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| -Less:Other special charges | ---- | --606K | --8.43M | --4.53M | --3.9M | ---- | ---- | ---- | ---- | ---- |
| -Write off | ---- | ---- | 31.32%10.77M | ---- | ---- | ---- | ---- | --8.2M | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | --3.48M | --0 | --3.48M | ---- | ---- | --0 | --0 | --0 |
| Income before tax | -32.24%-14.01M | -397.20%-46.24M | -55.49%-61.45M | -192.24%-45.16M | -156.15%-19.91M | 91.63%-10.59M | -454.83%-9.3M | -121.42%-39.52M | 58.05%48.97M | 39.11%35.46M |
| Income tax | 58.17%-1.08M | -1,606.72%-14.47M | 35.55%-4.35M | -15.44%-3.93M | -119.64%-1.94M | 81.95%-2.58M | -183.22%-848K | -109.15%-6.75M | -139.41%-3.41M | 108.20%9.9M |
| Net income | -1,014.93%-50.33M | -583.77%-32.01M | -2.66%-70.69M | -436.80%-54.83M | -170.30%-17.97M | 95.98%-4.51M | 313.05%6.62M | -162.20%-68.86M | -27.12%16.28M | 23.27%25.56M |
| Net income continuous Operations | -61.29%-12.93M | -275.85%-31.77M | -74.25%-57.09M | -178.73%-41.23M | -170.30%-17.97M | 92.86%-8.02M | -627.59%-8.45M | -129.60%-32.77M | 134.48%52.37M | 23.27%25.56M |
| Net income discontinuous operations | -1,167.93%-37.4M | -101.62%-244K | 62.33%-13.6M | ---- | ---- | --3.5M | --15.07M | ---36.09M | ---- | ---- |
| Minority interest income | -275.79%-357K | -357.14%-288K | -280K | 60K | -182K | -95K | -63K | 0 | 0 | 0 |
| Net income attributable to the parent company | -1,030.82%-49.97M | -574.90%-31.72M | -2.25%-70.41M | -437.17%-54.89M | -169.59%-17.78M | 96.06%-4.42M | 316.98%6.68M | -162.18%-68.86M | -27.12%16.28M | 23.27%25.56M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1,030.82%-49.97M | -574.90%-31.72M | -2.25%-70.41M | -437.17%-54.89M | -169.59%-17.78M | 96.06%-4.42M | 316.98%6.68M | -162.18%-68.86M | -27.12%16.28M | 23.27%25.56M |
| Basic earnings per share | -975.00%-0.43 | -620.00%-0.26 | -25.53%-0.59 | -500.00%-0.48 | -188.89%-0.16 | 94.74%-0.04 | 400.00%0.05 | -166.20%-0.47 | -20.00%0.12 | 28.57%0.18 |
| Diluted earnings per share | -975.00%-0.43 | -620.00%-0.26 | -25.53%-0.59 | -536.36%-0.48 | -188.89%-0.16 | 94.74%-0.04 | 400.00%0.05 | -166.20%-0.47 | -26.67%0.11 | 28.57%0.18 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg